CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
USG PECS2 with Drug A (active) +3 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03555227
NCT03555227N/ACompleted
CompareCT.gov

Ultrasound Guided (USG) PECS Versus Local Infiltration Anaesthesia (LIA) for Breast Cancer Surgery - A Randomized Quadruple Blinded Efficacy and Safety Study

National Health Service, United Kingdom·interventional·Posted Jun 13, 2018·Updated Nov 29, 2018

In Brief

A clinical study evaluating USG PECS2 with Drug A (active), USG PECS2 with Drug P (placebo), and 2 other interventions for Breast Cancer Female. Completed, enrolled 110 participants across 1 site.

Detailed Summary

Breast cancer is the most common cancer for which women in the UK (United Kingdom) undergo surgery. A novel ultrasound guided regional anaesthetic technique called the 'Pecs 2' block has recently been described. This study compares ultrasound guided (USG) Pecs 2 block with local anaesthetic infiltration (LIA) for pain relief following breast cancer surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer Female
CountriesUnited Kingdom
CollaboratorsSouthern Health and Social Care Trust

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 13, 2018
Enrollment StartSep 25, 2017
Primary CompletionNov 25, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.1 years ago

Interventions

USG PECS2 with Drug A (active)procedure

Ultrasound guided Pecs 2 blocks with 0.25% levobupivacaine

USG PECS2 with Drug P (placebo)procedure

Ultrasound guided Pecs 2 blocks with placebo (0.9% saline)

Wound infiltration with Drug P (placebo)procedure

Wound infiltration at the end of surgery with Drug P (0.9% saline)

Wound infiltration with Drug A (active)procedure

Wound infiltration at the end of surgery with 0.25% levobupivacaine